erythromycin has been researched along with Bronchopulmonary Dysplasia in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (66.67) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, C; Chu, X; Weng, B; Yin, X; Zhang, X | 1 |
| Schelonka, RL; Waites, KB | 1 |
| Speer, CP; Thomas, W | 1 |
| Cassell, GH; Crouse, DT; Waites, KB | 1 |
| Bucci, G; Chiesa, C; Pacifico, L; Panero, A; Roggini, M; Rossi, N | 1 |
| Andreu Domingo, A; Cabero Roura, L; Campins Martí, M; Casellas Caro, M; Fernández Pérez, F; Lucaya Layret, J; Peguero Monforte, G; Perapoch López, J; Salcedo Abizanda, S; Torán Fuentes, N | 1 |
| Hashimoto, T; Nishigaki, K; Okura, M; Ono, T; Sato, Y; Takeuchi, Y | 1 |
| Guggenbichler, JP; Heininger, U; Stehr, K; Storr, U; Uberall, MA | 1 |
| Abele-Horn, M; Hentschel, J | 1 |
4 review(s) available for erythromycin and Bronchopulmonary Dysplasia
| Article | Year |
|---|---|
Ureaplasma infection and neonatal lung disease.
Topics: Anti-Bacterial Agents; Bronchopulmonary Dysplasia; Chorioamnionitis; Erythromycin; Female; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Premature Birth; Ureaplasma; Ureaplasma Infections | 2007 |
Prevention and therapy of bronchopulmonary dysplasia - evidence and clinical practice.
Topics: Antioxidants; Bronchopulmonary Dysplasia; Caffeine; Diuretics; Erythromycin; Humans; Incidence; Infant, Newborn; Nitric Oxide; Oxygen; Ureaplasma urealyticum | 2007 |
Therapeutic considerations for Ureaplasma urealyticum infections in neonates.
Topics: Bronchopulmonary Dysplasia; Drug Resistance, Microbial; Erythromycin; Humans; In Vitro Techniques; Infant, Newborn; Respiratory Tract Infections; Ureaplasma Infections; Ureaplasma urealyticum | 1993 |
[Administration of intrapartum erythromycin for the interruption of the vertical transmission of Ureaplasma urealyticum and its possible relation to the development of bronchopulmonary dysplasia in neonates with less than 32 weeks gestation. Multicenter s
Topics: Anti-Bacterial Agents; Bronchopulmonary Dysplasia; Erythromycin; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Infectious Disease Transmission, Vertical; Ureaplasma Infections; Ureaplasma urealyticum | 1997 |
2 trial(s) available for erythromycin and Bronchopulmonary Dysplasia
| Article | Year |
|---|---|
[Administration of intrapartum erythromycin for the interruption of the vertical transmission of Ureaplasma urealyticum and its possible relation to the development of bronchopulmonary dysplasia in neonates with less than 32 weeks gestation. Multicenter s
Topics: Anti-Bacterial Agents; Bronchopulmonary Dysplasia; Erythromycin; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Infectious Disease Transmission, Vertical; Ureaplasma Infections; Ureaplasma urealyticum | 1997 |
[Multicenter study on clinical effects of a small dose of erythromycin on chronic lung disorders of premature infants--single blind comparison of treated and untreated groups. A committee for the Study of EM Therapy for Chronic Lung Diseases of Premature
Topics: Anti-Bacterial Agents; Bronchopulmonary Dysplasia; Erythromycin; Humans; Infant, Newborn; Respiratory Distress Syndrome, Newborn; Single-Blind Method | 1998 |
4 other study(ies) available for erythromycin and Bronchopulmonary Dysplasia
| Article | Year |
|---|---|
Erythromycin Attenuates Hyperoxia Induced Lung Injury by Enhancing GSH Expression and Inhibiting Expression of Inflammatory Cytokines.
Topics: Animals; Animals, Newborn; Bronchopulmonary Dysplasia; Chlorides; Cytokines; Disease Models, Animal; Erythromycin; Hyperoxia; Inflammation; Lung; Lung Injury; Rats; Tumor Necrosis Factor-alpha | 2023 |
Ureaplasma urealyticum and pulmonary outcome in a neonatal intensive care population.
Topics: Bronchopulmonary Dysplasia; Chronic Disease; Erythromycin; Female; Humans; Infant, Newborn; Infant, Very Low Birth Weight; Intensive Care Units, Neonatal; Male; Nasopharynx; Pneumonia, Bacterial; Prospective Studies; Ureaplasma urealyticum | 1997 |
[Pertussis--an illness with typical clinical symptoms?].
Topics: Administration, Oral; Bordetella pertussis; Bronchopulmonary Dysplasia; Child, Preschool; Cyanosis; Diagnosis, Differential; Erythromycin; Heart Failure; Humans; Infant; Infant, Newborn; Male; Nasopharynx; Whooping Cough | 1992 |
[Ureaplasma urealyticum in newborn and premature infants. Its association with bronchopulmonary dysplasia].
Topics: Bronchopulmonary Dysplasia; Erythromycin; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Male; Microbial Sensitivity Tests; Pilot Projects; Ureaplasma Infections; Ureaplasma urealyticum | 1992 |